YURIKO FUKUTA to Immunization, Passive
This is a "connection" page, showing publications YURIKO FUKUTA has written about Immunization, Passive.
Connection Strength
0.701
-
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial. JCI Insight. 2024 Mar 14; 9(8).
Score: 0.215
-
Early Outpatient Treatment for Covid-19 with Convalescent Plasma. N Engl J Med. 2022 05 05; 386(18):1700-1711.
Score: 0.187
-
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial. Microbiol Spectr. 2024 Jan 11; 12(1):e0328623.
Score: 0.053
-
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials. Transfusion. 2023 09; 63(9):1639-1648.
Score: 0.051
-
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial. J Infect Dis. 2023 05 29; 227(11):1266-1273.
Score: 0.051
-
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. Clin Infect Dis. 2023 02 08; 76(3):e477-e486.
Score: 0.050
-
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern. Blood Adv. 2022 06 28; 6(12):3678-3683.
Score: 0.048
-
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19? Transfusion. 2022 05; 62(5):933-941.
Score: 0.047